Egypt Syringes, Auto Disable Syringe and IV Cannulas Market – Industry Trends and Forecast to 2030

Egypt Syringes, Auto Disable Syringe, And IV Cannulas Market Analysis and Size

The rise in the number of vaccinations because of COVID-19 and the increase in incidence of chronic diseases are the major factors boosting the market's growth in the forecast period 2023-2030. Furthermore, several organizations are gaining much knowledge in their end-to-end supply chains to minimize product prices and enhance the quality and services related to disposable syringes. It has been found that safety syringes have dominated the market growth over the years.

Data Bridge Market Research analyses a growth rate in the syringes, auto disabled syringe, and IV cannulas market in the forecast period 2023-2030. The expected CAGR of the syringes, auto disable syringe and IV cannulas market tend to be around 5.10% in the mentioned forecast period. The market was valued at USD 53.61 million in 2022 and would grow to USD 79.81 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Egypt Syringes, Auto Disable Syringe, And IV Cannulas Market Scope and Segmentation

Market Definition

A syringe is a medical device that helps administer fluids into the body and even draws them from the body. These syringes have a nozzle at the end of the hollow cylinder whose upward movement aids in drawing the fluid, whereas lower movement helps administer fluids. Auto-disable syringes control the administration of fluids in the body. These syringes cannot be reused as it gets automatically blocked once the dose has been administered.

Syringes, Auto Disable Syringe, And IV Cannulas Market Dynamics

Drivers

• Growing Demand for Conventional Syringes

Conventional syringes seem to gain much revenue for the market during the forecast period. Conventional syringes are typically made of plastic with visible graduation and are planned for single use. Conventional disposable syringes' major benefits are that they remove the risk of infections from blood-borne pathogens, such as the Ebola virus, HIV, and Hepatitis B & C. Thus, this factor will boost market growth.

• Increasing Demand for Advanced Injector Technology

With the introduction of advanced injector technology, the patient is never in contact with a needle, which was a great boon to the market growth. In this process, after attaching the injector and pressing the button, the needle is inserted. The patient is being kept in awareness with audible, tactile, and visual indications as the medicine is released and the needle automatically retracts and locks out, ensuring safe and suitable disposal of the device. With the wide use of syringes, auto disable syringe and IV cannulas, there would be no needle stick injuries than the intravenous injectable and parenteral administration. Thus, this factor boosts the market growth.

Opportunities

• Increased Healthcare Expenditure

The rising expenditure associated with the production of syringes and cannulas led to the market's growth. For instance, in 2021, Polymedicure's QIP committee approved the allotment of 76,33,587 equity shares to eligible, qualified institutional buyers at the issue price of Rs 524 per equity share, aggregating to Rs 400 crore. Also, polymedicure plans to use the total proceeds to support acceptable organic and inorganic development opportunities, continuing capital spending, other long-term and short-term provisions, and prepayment or redemption of unpaid borrowings. This factor will boost the market growth.

• Increasing Product Launches

Several product launches and agreements are also initiated by the companies globally, which are also increasing the market growth. For instance, syringe manufacturer B.D. supplied the U.S. government with around 286 million syringes for use with COVID-19 vaccines, including around 40 million low-dead space syringes, and this arrangement was initiatied in 2021. This will boost the supply chain of the company.

Restraints/Challenges

• Lack of Resources and Waste Management Research

Several concerns are associated with medical waste disposal due to a lack of resources, incorrect disposal methods, and lack of waste management research. According to an article by EcoMENA in 2019, Egypt created 28,300 tonnes of medical waste in 2010. Thus, this factor restricts the market growth.

This syringes, auto disable syringe and IV cannulas market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the syringes, auto disable syringe and IV cannulas market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Egypt Syringes, Auto Disable Syringe, And IV Cannulas Market Scope

The syringes, auto disable syringe and IV cannulas market is segmented on the basis of type, usage, IV therapy, material, lock system, Volume, gauge size, indication, application, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type 

• General Syringes
• Specialized Syringes
• Smart Syringes

Usage

• Reusable Syringes
• Disposable Syringes

Material

• Polypropylene Barrel
• Rubber Plunger
• Lubricant – Silicone Oil

Lock System

• Barrel Seal Lock System
• Top Plunger Lock System

Volume

• 0.05ML
• 0.1ML
• 0.3ML
• 0.5ML
• 1ML
• Others

Gauge Size

• 14G TO 16G
• 17G TO 20G
• 22G TO 26G

IV Therapy

• Central IV Cannula
• Midline IV Cannula
• Peripheral IV Cannula

Indication

• Vaccines
• Infectious Diseases
• Inflammatory & Auto-Immune Diseases
• Others

Application

• Blood Collection
• Vaccination
• Drug Delivery
• Others

End-user

• Hospitals
• Clinics
• Research Laboratories
• Ambulatory Centers
• Others

Distribution Channel

• Pharmacies
• Specialty Stores
• Online
• Others

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The syringes, auto disable syringe and IV cannulas market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for syringes, auto disable syringe and IV cannulas market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the syringes, auto disable syringe and IV cannulas market. The data is available for historic period 2011-2021.

Competitive Landscape and Egypt Syringes, Auto Disable Syringe And IV Cannulas Market Share Analysis

The syringes, auto disable syringe and IV cannulas market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Egypt presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related syringes, auto disable syringe and IV cannulas market.

Key players operating in the syringes, auto disable syringe and IV cannulas market include:

• B.D. (U.S)
• American Equipment Company, Inc (U.S.)
• Polymedicure (India)
• Intermedica, Inc. (Poland)
• Denex International (India)
• Ultramedumic (Canada)

SKU-61046